Dose-response relationship in tobacco-related cancers of bladder and lung: A biochemical interpretation

International Journal of Cancer

Volumn 108, Issue 1, 2004, Pages 2-7

  Vineis, Paolo ^a   Alavanja, Michael ^b   Garte, Seymour ^c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Genetics Research Institute   (Italy)

^d Center for the History and Ethics of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; AROMATIC AMINE; TOBACCO SMOKE;

ACETYLATOR PHENOTYPE; BLADDER CANCER; CANCER RISK; CARCINOGENIC ACTIVITY; CHEMICAL ANALYSIS; CIGARETTE SMOKING; DOSE RESPONSE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; MATHEMATICAL COMPUTING; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; TOBACCO;

CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING; TOBACCO SMOKE POLLUTION; URINARY BLADDER NEOPLASMS;

EID: 0344825137     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11467     Document Type: Short Survey

References (38)

1. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000;463:103-10.
2. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 38. Tobacco smoking. Lyon: IARC, 1986.
3. Steenland K, Deddens J, Piacitelli L. Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study. Am J Epidemiol 2001;154:451-8.
4. Watanabe PG, Zempel JA, Gehring PJ. Comparison of the fate of vinyl chloride following single and repeated exposure in rats. Toxicol Appl Pharmacol 1978;44:391-9.
5. Hertz-Picciotto I, Smith AH. Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health 1993;19:217-26.
6. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86:712-6.
7. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-45.
8. Vineis P, Caporaso N, Cuzick J, Lang M, Malats N, Boffetta P. Genetic susceptibility to cancer: metabolic polymorphisms. IARC Scientific Publication No. 148. Lyon: IARC, 1999.
9. Vineis P, Bartsch H, Caporaso N, Harrington A, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, Tannenbaum SR. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-6.
10. Taioli E, Zocchetti C, Garte S. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 1998;106:67-70.
11. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997;315:980-8.
12. Lubin JH. Estimating lung cancer risk with exposure to environmental tobacco smoke. Environ Health Perspect 1999;107(Suppl 6):879-83.
13. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
14. Bennett WP, Alavanja MC, Blomeke B, Vahakangas KH, Castren K, Welsh JA, Bowman ED, Khan MA, Flieder DB, Harris CC. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999;91:2009-14.
15. Harris RE, Chen-Backlund JY, Wynder EL. Cancer of the urinary bladder in blacks and whites. A case-control study. Cancer 1990;66:2673-80.
16. De Stefani E, Correa P, Fierro L, Fontham E, ChenV, Zavala D. Black tobacco, mate, and bladder cancer. A case-control study from Uruguay. Cancer 1991;67:536-40.
17. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 1992;69:1776-90.
18. Vena JE, Freudenheim J, Graham S, Marshall J, Zielezny M, Swanson M, Sufrin G. Coffee, cigarette smoking, and bladder cancer in western New York. Ann Epidemiol 1993;3:586-91.
19. Momas I, Daures JP, Festy B, Bontoux J, Gremy F. Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 1994;10:599-604.
20. Steineck G, Norell SE, Feychting M. Diet, tobacco and urothelial cancer. A 14-year follow-up of 16,477 subjects. Acta Oncol 1988;27:323-7.
21. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF. Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int J Cancer 1995;60:190-3.
22. Akiba S, Hirayama T. Cigarette smoking and cancer mortality risk in Japanese men and women-results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 1990;17:19-26.
23. Mills PK, Beeson WL, Phillips RL, Fraser GE. Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 1991;133:230-9.
24. Kuller LH, Ockene JK, Meilahn E, Wentworth DN, Svendsen KH, Neaton JD. Cigarette smoking and mortality. MRFIT Research Group. Prev Med 1991;20:638-54.
25. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol 1993;3:211-6.
26. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996;7:497-506.
27. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6:863-73.
28. Garfinkel L, Stellman SD. Smoking and lung cancer in women: findings in a prospective study. Cancer Res 1988;48:6951-5.
29. Stellman SD, Garfinkel L. Lung cancer risk is proportional to cigarette tar yield: evidence from a prospective study. Prev Med 1989;18:518-25.
30. Kuller LH, Ockene JK, Meilahn E, Wentworth DN, Svendsen KH, Neaton JD. Cigarette smoking and mortality. Prev Med 1991;20:638-54.
31. Chow WH, Schuman LM, McLaughlin JK, Bjelke E, Gridley G, Wacholder S, Chien HT, Blot WJ. A cohort study of tobacco use, diet, occupation, and lung cancer mortality. Cancer Causes Control 1992;3:247-54.
32. Potter JD, Sellers TA, Folsom AR, McGovern PG. Alcohol, beer, and lung cancer in postmenopausal women. The Iowa Women's Health Study. Ann Epidemiol 1992;2:587-95.
33. Freund K, Belanger AJ, D'Agostino RB, Kannel WB. The health risks of smoking: the Framingham Study, 34 years of follow-up. AEP 1993:417-24.
34. Sidney S, Tekewa IS, Friedman GD. A prospective study of cigarette tar yield and lung cancer. Cancer Causes Control 1993;4:3-10.
35. Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 1994;3:289-98.
36. Engeland A, Haldorson T, Anderson A, Tretli S. The impact of smoking habits on lung cancer risk; 28 years' observation of 26,000 Norwegian men and women Cancer Causes Control 1996;7:366-76.
37. Tulinius H, Sigfusson N, Bjarndottir K, Tyggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Prev 1997;6:863-73.
38. Nordlund LA, Cartensen JM, Pershagen G. Are male and female smokers at equal risk of smoking-related cancer: evidence from a Swedish prospective study. Scand J Public Health 1999;1:56-62.